<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04483037</url>
  </required_header>
  <id_info>
    <org_study_id>CCH IRB No.: 181216</org_study_id>
    <nct_id>NCT04483037</nct_id>
  </id_info>
  <brief_title>Different Dosing Time of Bowklean for the Bowel Preparation</brief_title>
  <official_title>Comparison of Same-Day and Split-Dose Preparation With Sodium Picosulfate/Magnesium Citrate (Bowklean) for Afternoon Colonoscopy: A Randomized Non-Inferiority Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhua Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhua Christian Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare the efficacy of administration routine&#xD;
      bowel cleansing medication (Bowklean) for the Bowel Preparation at Different Times Prior&#xD;
      Colonoscopy in the morning or in the afternoon.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sodium picosulfate/magnesium citrate (SPMC) is a small-volume bowel cleansing agent with&#xD;
      similar efficacy and better tolerability than polyethylene glycol. However, there was limited&#xD;
      data about the bowel cleansing efficacy of SPMC in comparing the same-day and split-dose&#xD;
      preparation for afternoon colonoscopy.&#xD;
&#xD;
      This randomized, single-center, endoscopist-blinded, non-inferior study compared same-day&#xD;
      (101 subjects) and split-dose (96 subjects) preparation with SPMC for afternoon colonoscopy.&#xD;
      One additional prospective observation group of 100 subjects receiving colonoscopy in the&#xD;
      morning was included as an observation group to compare bowel preparation in morning and&#xD;
      afternoon colonoscopy. Efficacy of bowel cleansing was evaluated by the Aronchick Scale,&#xD;
      Ottawa Bowel Preparation Scale (OBPS), Boston Bowel Preparation Scale (BBPS), and the Bubble&#xD;
      Scale (TBS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The 1st group: split dose, day before, colonoscopy in the morning. The 2nd group: split dose, day before, colonoscopy in the afternoon. The 3rd group: same day, colonoscopy in the afternoon.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aronchick Scale Bowel Cleaning Scale</measure>
    <time_frame>during colonoscopy</time_frame>
    <description>Aroochick Scale ranges from score 1 : excellent, 2: good, 3: fair, 4: poor 5: failed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Boston Bowel Preparation Scale (BBPS) Bowel Cleaning Scale</measure>
    <time_frame>During Colonoscopy</time_frame>
    <description>The Boston Bowel Preparation Scale Score 0 : inadequate ; Score 1: fair ;Score 2: good; Score 3: excellent . min : 0 , max: 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colonscopy Bubble Scale</measure>
    <time_frame>During Colonoscopy</time_frame>
    <description>Colon Bubble Scale : Grade A : no bubble , Grade B: little bubble , Grade C: bubble of half of the lumen , Grade D: bubble of entire lumen. Grade A means the best and Grade D means the worst.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">297</enrollment>
  <condition>Bowel Preparation</condition>
  <arm_group>
    <arm_group_label>split dose, day before, colonoscopy in the morning (Observation Group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>routine bowel preparation before colonoscopy in the morning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>split dose, day before, colonoscopy in the afternoon (Random)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>routine bowel preparation before colonoscopy in the afternoon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>two dose in the same day, colonoscopy in the afternoon (Random)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>experimental group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bowklean</intervention_name>
    <description>assigned intervention</description>
    <arm_group_label>split dose, day before, colonoscopy in the afternoon (Random)</arm_group_label>
    <arm_group_label>split dose, day before, colonoscopy in the morning (Observation Group)</arm_group_label>
    <arm_group_label>two dose in the same day, colonoscopy in the afternoon (Random)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is 20 and 99 years, inclusive.&#xD;
&#xD;
          2. Men or non-pregnant women who are scheduled for an elective colonoscopy.&#xD;
&#xD;
          3. Subjects should be willing, able to complete the entire procedure and to comply with&#xD;
             study instructions.&#xD;
&#xD;
          4. Written informed consent obtained prior to study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who are not suitable for colonoscopy&#xD;
&#xD;
               -  Acute surgical abdominal conditions (e.g. acute obstruction or perforation, etc.)&#xD;
&#xD;
               -  Active (acute/exacerbation of/severe/uncontrolled) Inflammatory Bowel Disease&#xD;
                  (IBD)&#xD;
&#xD;
               -  Colon disease (history of colonic cancer, toxic megacolon, toxic colitis,&#xD;
                  idiopathic pseudo- obstruction, hypomotility syndrome)&#xD;
&#xD;
               -  Gastrointestinal disorder (active ulcer, outlet obstruction, gastric retention,&#xD;
                  gastroparesis, ileus)&#xD;
&#xD;
               -  Uncontrolled angina and/or Myocardial Infarction (MI) within last 3 months before&#xD;
                  randomization, Congestive Heart Failure (CHF), arrhythmia, cardiomyopathy or&#xD;
                  uncontrolled hypertension&#xD;
&#xD;
               -  Renal insufficiency&#xD;
&#xD;
          2. Any prior colorectal surgery&#xD;
&#xD;
               -  in the past 3 months, excluding appendectomy, hemorrhoid surgery or prior&#xD;
                  endoscopic procedures&#xD;
&#xD;
               -  History of upper gastrointestinal surgery (gastric resection, gastric banding,&#xD;
                  gastric by-pass)&#xD;
&#xD;
          3. Severe chronic constipation&#xD;
&#xD;
          4. Hypersensitivity to any ingredient in the study medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HsuHeng Yen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changhua Christian Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hsu-Heng Yen</name>
      <address>
        <city>Changhua</city>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 20, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhua Christian Hospital</investigator_affiliation>
    <investigator_full_name>HSUHENG YEN</investigator_full_name>
    <investigator_title>Head of Endoscopy Room</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

